Author
Listed:
- C. K. Deniston
(University of California San Diego
Genomics Institute of the Novartis Research Foundation)
- J. Salogiannis
(University of California San Diego
Howard Hughes Medical Institute)
- S. Mathea
(Goethe-Universität)
- D. M. Snead
(University of California San Diego)
- I. Lahiri
(University of California San Diego
Indian Institute of Science Education and Research Mohali)
- M. Matyszewski
(University of California San Diego)
- O. Donosa
(Howard Hughes Medical Institute)
- R. Watanabe
(University of California San Diego
La Jolla Institute for Immunology)
- J. Böhning
(University of California San Diego
Oxford University)
- A. K. Shiau
(Ludwig Institute for Cancer Research
University of California San Diego)
- S. Knapp
(Goethe-Universität)
- E. Villa
(University of California San Diego)
- S. L. Reck-Peterson
(University of California San Diego
Howard Hughes Medical Institute
University of California San Diego)
- A. E. Leschziner
(University of California San Diego
University of California San Diego)
Abstract
Leucine-rich repeat kinase 2 (LRRK2) is the most commonly mutated gene in familial Parkinson’s disease1 and is also linked to its idiopathic form2. LRRK2 has been proposed to function in membrane trafficking3 and colocalizes with microtubules4. Despite the fundamental importance of LRRK2 for understanding and treating Parkinson’s disease, structural information on the enzyme is limited. Here we report the structure of the catalytic half of LRRK2, and an atomic model of microtubule-associated LRRK2 built using a reported cryo-electron tomography in situ structure5. We propose that the conformation of the LRRK2 kinase domain regulates its interactions with microtubules, with a closed conformation favouring oligomerization on microtubules. We show that the catalytic half of LRRK2 is sufficient for filament formation and blocks the motility of the microtubule-based motors kinesin 1 and cytoplasmic dynein 1 in vitro. Kinase inhibitors that stabilize an open conformation relieve this interference and reduce the formation of LRRK2 filaments in cells, whereas inhibitors that stabilize a closed conformation do not. Our findings suggest that LRRK2 can act as a roadblock for microtubule-based motors and have implications for the design of therapeutic LRRK2 kinase inhibitors.
Suggested Citation
C. K. Deniston & J. Salogiannis & S. Mathea & D. M. Snead & I. Lahiri & M. Matyszewski & O. Donosa & R. Watanabe & J. Böhning & A. K. Shiau & S. Knapp & E. Villa & S. L. Reck-Peterson & A. E. Leschzin, 2020.
"Structure of LRRK2 in Parkinson’s disease and model for microtubule interaction,"
Nature, Nature, vol. 588(7837), pages 344-349, December.
Handle:
RePEc:nat:nature:v:588:y:2020:i:7837:d:10.1038_s41586-020-2673-2
DOI: 10.1038/s41586-020-2673-2
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Riley D. Metcalfe & Juliana A. Martinez Fiesco & Luis Bonet-Ponce & Jillian H. Kluss & Mark R. Cookson & Ping Zhang, 2023.
"Structure and regulation of full-length human leucine-rich repeat kinase 1,"
Nature Communications, Nature, vol. 14(1), pages 1-17, December.
- Xingjian Li & Hanwen Zhu & Bik Tzu Huang & Xianting Li & Heesoo Kim & Haiyan Tan & Yuanxi Zhang & Insup Choi & Junmin Peng & Pingyi Xu & Ji Sun & Zhenyu Yue, 2024.
"RAB12-LRRK2 complex suppresses primary ciliogenesis and regulates centrosome homeostasis in astrocytes,"
Nature Communications, Nature, vol. 15(1), pages 1-16, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:588:y:2020:i:7837:d:10.1038_s41586-020-2673-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.